Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Launched by NATIONAL CANCER INSTITUTE (NCI) · Sep 24, 2011

Keywords

ClinConnect Summary

This clinical trial is studying how certain genes may affect the way people with cancer respond to treatment. Researchers believe that some genes can influence the side effects of treatment and how effective it is. To learn more, they are collecting blood or cheek swab samples from patients undergoing treatment for cancers like prostate, breast, lung, ovarian, and lymphoma. By examining these samples, the team hopes to identify genetic differences that could help improve cancer care in the future.

To participate in this study, you need to be at least 3 years old and currently receiving treatment for cancer or related conditions at the National Cancer Institute. If you join, you will provide a blood sample, or a cheek swab if you have a blood-related cancer like leukemia. If the initial sample doesn’t have enough genetic material, another sample might be requested. This study is open to anyone, regardless of gender, and is currently looking for participants. Your involvement could contribute to important discoveries that help others with cancer.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.
• • Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.
• • Age \>= 3 years old
• EXCLUSION CRITERIA:
• • -N/A